Ultrasound-Guided Dextrose Hydrodissection of the Median Nerve

The goal of this clinical trial is to evaluate the clinical and ultrasonographic outcomes of ultrasound-guided median nerve hydrodissection with 5% dextrose in patients with mild and moderate carpal tunnel syndrome. The main questions it aims to answer are: * Does ultrasound-guided dextrose hydrodissection improve pain and functional status in patients with carpal tunnel syndrome? * Does this procedure lead to changes in ultrasonographic parameters of the median nerve? * Is ultrasound-guided dextrose hydrodissection a safe procedure in this patient population? Participants will: * Undergo a single session of ultrasound-guided median nerve hydrodissection with 5% dextrose * Be evaluated before the procedure and at 1-month and 3-month follow-up visits using clinical outcome measures and ultrasound assessment * Be monitored for any procedure-related adverse events

NCT Number	NCT07371221
Lead Sponsor	Dr. Nafiz Korez Sincan State Hospital
Conditions	Carpal Tunnel Syndrome (CTS)
Enrollment	37 participants
Start Date	2024-06-17
Primary Completion	2025-06-26 (estimated)
Study Completion	2025-06-26 (estimated)
Updated on ClinicalTrials.gov	2026-01-30